Inhaling xenon ameliorates l‐dopa‐induced dyskinesia in experimental parkinsonism

Parkinson's disease motor symptoms are treated with levodopa, but long‐term treatment leads to disabling dyskinesia. Altered synaptic transmission and maladaptive plasticity of corticostriatal glutamatergic projections play a critical role in the pathophysiology of dyskinesia. Because the noble...

Descripción completa

Detalles Bibliográficos
Autores principales: Baufreton, Jérôme, Milekovic, Tomislav, Li, Qin, McGuire, Steve, Moraud, Eduardo Martin, Porras, Grégory, Sun, Shiqi, Ko, Wai Kin D., Chazalon, Marine, Morin, Stéphanie, Normand, Elisabeth, Farjot, Géraldine, Milet, Aude, Pype, Jan, Pioli, Elsa, Courtine, Gregoire, Bessière, Baptiste, Bezard, Erwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221147/
https://www.ncbi.nlm.nih.gov/pubmed/29756234
http://dx.doi.org/10.1002/mds.27404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221147/
https://www.ncbi.nlm.nih.gov/pubmed/29756234
http://dx.doi.org/10.1002/mds.27404

Ejemplares similares